Reviva shares surge 17.73% intraday as positive reviews highlight effective Reviva Glow formula with hyaluronic acid and vitamin C.

Reviva surged 17.73% intraday following positive reviews highlighting its skincare product Reviva Glow. News emphasized the product's effective formulation with hyaluronic acid, vitamin C, and retinol, which target aging, uneven tone, and dullness. Reviews praised its fast-acting results, cruelty-free status, and suitability for sensitive skin, with users reporting visible improvements in firmness and radiance. The product's ethical production and dermatologist-tested formula further reinforced consumer confidence. These factors likely drove strong investor sentiment, aligning with the stock's sharp intraday rally as market participants reacted to the product's market traction and potential revenue growth.